LM Diagnósticos S.L.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Effect of Dapagliflozin on Nighttime Blood Pressure in Type 2 Diabetes (NCT03887416) | LM Diagnósticos S.L. | 2019-04-12 |
Track LM Diagnósticos S.L. automatically
Every clearance here is in the API, with alerts when new ones post.